These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8183562)

  • 1. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
    Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
    Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
    Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
    Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shb is a ubiquitously expressed Src homology 2 protein.
    Welsh M; Mares J; Karlsson T; Lavergne C; Bréant B; Claesson-Welsh L
    Oncogene; 1994 Jan; 9(1):19-27. PubMed ID: 8302579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; García LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
    Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
    Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
    Reichman CT; Mayer BJ; Keshav S; Hanafusa H
    Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation.
    Tachibana M; Kiyokawa E; Hara S; Iemura S; Natsume T; Manabe T; Matsuda M
    Exp Cell Res; 2009 Mar; 315(5):863-76. PubMed ID: 19118547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF.
    Akakura S; Kar B; Singh S; Cho L; Tibrewal N; Sanokawa-Akakura R; Reichman C; Ravichandran KS; Birge RB
    J Cell Physiol; 2005 Jul; 204(1):344-51. PubMed ID: 15700267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CrkIII: a novel and biologically distinct member of the Crk family of adaptor proteins.
    Prosser S; Sorokina E; Pratt P; Sorokin A
    Oncogene; 2003 Jul; 22(31):4799-806. PubMed ID: 12894221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Src association with and phosphorylation of p58gag, a membrane- and microfilament-associated retroviral Gag-like protein in a xenotransplantable rat mammary tumor.
    Huang J; Zhang BT; Li Y; Mayer B; Carraway KL; Carraway CA
    Oncogene; 1999 Jul; 18(28):4099-107. PubMed ID: 10435591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
    J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.